Advantis Corp. Setting Up Multi-State Amster-Can Canning Solutions
August 21 2017 - 9:25AM
InvestorsHub NewsWire
NEWPORT BEACH, CA--(NewMediaWire - Aug 21, 2017) - ADVANTIS
CORPORATION (OTC PINK: ADVT) is finalizing agreements with
client partners in Oregon and Las Vegas, Nevada to package their
goods in with Amster-Can.
Advantis CEO, Christipher Swartz, was excited to share the news
of what he has been working on for the past several months.
"Canning cannabis is the gold standard of packaging, branding, and
preservation," Swartz said. "Advantis set up partnerships in Oregon
and Washington last year and have been working on developing
partnerships that make sense before we establish operations in
these areas. To that end, we finally found the right partners in
Oregon and made a new client in Nevada; we expect to set up
full-scale canning operations in both states, and will have the
pending orders to support our expansion." Swartz added that the
agreements are not finalized yet, but things will move quickly when
they are.
Swartz says that their success in California is what is fueling
the company's expansion. "Over the next sixteen months canning will
become a necessity here in California. With the new regulations
requiring specific package requirements and child proofing, we are
poised to be the go-to place for all canning needs." Advantis has
an agreement with N2Pack to provide packaging solutions using their
patented technology; Advantis branded its canning service as
Amster-Can. N2pack has been a solid partner and has solidified that
partnership by building a more efficient canning machine for
Advantis to keep up with demand. "We are actively expanding our
reach and establishing our brand in key markets that will sustain
our business plan for the foreseeable future," Swartz concluded.
"Amster-Can is quickly becoming a household name."
Links to Advantis websites can be found
at advantiscorp.com, elixicure.com,
and amstercan.com
Social Media Links Instagram Facebook
About Advantis Corporation
Advantis Corporation (ADVT) focuses on the development of
innovative products that supply the medical, research, and
pharmaceutical industries. The company additionally establishes
partnerships with businesses that develop and sell proprietary pain
management, and consumer products and services.
Forward Looking Statements: This news release contains
forward-looking statements made by ADVANTIS CORPORATION. All such
statements included in this press release, other than statements of
historical fact, are forward-looking statements. Although
management believes that the expectations reflected in such
forward-looking statements are reasonable, it can give no assurance
that such expectations will prove to have been correct. Actual
results may differ materially from those indicated by these
statements. The following risk factors, among others, could cause
actual results to differ materially from those described in any
forward-looking statements. These risks and uncertainties include,
but are not limited to, economic conditions, changes in the law or
regulations, demand for products of the Company, the effects of
competition and other factors that could cause actual results to
differ materially from those projected or represented in the
forward looking statements. Forward-looking statements are
typically identified by the words: believe, expect, anticipate,
intend, estimate, and similar expressions or which by their nature
refer to future events. The Company is not entitled to rely on the
safe harbor provisions of Section 27A of the Securities Act of 1933
and Section 21E of the Securities Exchange Act of 1934 because it
is not registered under either Act.
CONTACT INFORMATION
For further information, contact:
Media Relations Contact Name:
Woo Kim
Director
Organization: Advantis Corporation
Phone: 949-354-3585
Address: 1048 Irvine Ave. #900 Newport Beach, CA 92660
E-mail: info@advantiscorp.com
Advantis (CE) (USOTC:ADVT)
Historical Stock Chart
From Nov 2024 to Dec 2024
Advantis (CE) (USOTC:ADVT)
Historical Stock Chart
From Dec 2023 to Dec 2024